3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia
10
Leukemia, Lymphocytic, Chronic, B-Cell
9
Congenital Abnormalities
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
7
Multiple Myeloma
6
Lymphoma, Mantle-Cell
6
Waldenstrom Macroglobulinemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Burkitt Lymphoma
5
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Squamous Cell Carcinoma of Head and Neck
3
Sezary Syndrome
3
Rectal Neoplasms
3
Mycosis Fungoides
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Hodgkin Disease
3
Interventions
Paclitaxel
177
Carboplatin
177
Bevacizumab
72
Topotecan
55
liposomal doxorubicin
54
Gemcitabine
53
Cisplatin
46
Docetaxel
39
Cyclophosphamide
37
olaparib
32
Filgrastim
31
pembrolizumab
29
Doxorubicin
26
niraparib
24
Taxes
23
Drug Therapy
23
Peripheral Blood Stem Cell Transplantation
20
Etoposide
17
veliparib
15
Nivolumab
14
sargramostim
13
Surveys and Questionnaires
13
Immunoglobulin G
13
Disulfides
13
pazopanib
12
Ifosfamide
12
Albumin-Bound Paclitaxel
12
durvalumab
11
atezolizumab
11
Trabectedin
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ovarian Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled